Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Experimental Medicine|May 1, 1990
Synthesis of granulocyte colony-stimulating factor and its requirement for terminal divisions in chronic myelogenous leukemiaH Klein, R Becher, M Lübbert, et al.
British Journal of Haematology|March 1, 1993
Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemiaO Kloke, N Niederle, J Y Qiu, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation. A preclinical pharmacology studyD W Beelen, R B Schilcher, R Ehrlich, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 6, 2019
An update on prevalence and risk of snus and nicotine replacement therapy during pregnancy and breastfeedingI Kreyberg, L S Nordhagen, K E S Bains, et al.
Klinische Wochenschrift|February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvumD Fritze, B Massner, R Becher, et al.
DNA and Cell Biology|June 17, 1998
Regulation of CCSP (PCB-BP/uteroglobin) expression in primary cultures of lung cells: involvement of C/EBPM Nord, M Låg, T N Cassel, et al.
British Journal of Haematology|August 1, 1992
Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemiaU B Wandl, O Kloke, M Nagel-Hiemke, et al.
Leukemia|June 1, 1991
In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disordersA Ganser, J W Janssen, O G Ottmann, et al.
Cancer Research|May 1, 1992
Metaphase and interphase cytogenetics with Alu-PCR-amplified yeast artificial chromosome clones containing the BCR gene and the protooncogenes c-raf-1, c-fms, and c-erbB-2C Lengauer, H C Riethman, M R Speicher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancerH Wilke, U Klaassen, W Achterrath, et al.
Pageof 18